PSU Watch logo

| PFC & REC to offer 10-year loans to state discoms at 9.5% |   | Union Bank of India cuts External Benchmark Lending Rate (EBLR) by 40 bps |   | Centre to sell stake in certain pharma PSUs: Goyal |   | NHAI to develop 57 stretches as model national highways |   | BEML to firm up partnerships with Czech, Japanese firms for setting up joint manufacturing facilities in India |  

COVID-19: BPPI contributes Rs 25 lakh to PM CARES fund

Bureau of Pharma PSUs of India (BPPI) has contributed Rs 25 lakh to PM CARES fund, to support nation’s fight against Coronavirus (COVID-19)

New Delhi: To support the government in its fight against Coronavirus (COVID-19), the Bureau of Pharma PSUs of India (BPPI), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has contributed Rs 25 lakh to PM CARES fund. According to the press release issued on Tuesday, the cheque of Rs 25 lakh was presented by Secretary (Pharma) PD Vaghela to Union Minister of Chemicals and Fertilizers DV Sadananda Gowda in New Delhi on Tuesday. On this occasion, BPPI’s CEO Sachin Singh, Joint Secretary (Pharma) Rajneesh Tingal, Joint Secretary (Pharma) Navdeep Rinwa and other senior officers were also present.
 
The amount was contributed by employees of BPPI and owners and distributors of Janaushadhi Kendras. The Kendras working under Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) have been rendering essential services to the nation. Bureau of Pharma PSUs of India (BPPI), the implementing agency of the PMBJP has been keeping a close tab on the situation in all of its area of operations. BPPI has been standing with its stakeholders and consumers in these challenging times as Pradhan Mantri Bhartiya Janaushadhi Kendra (PMBJK) are functional and maintaining operations as part of their commitment.

BPPI is committed to ensuring uninterrupted availability of essential medicines at the PMBJK. BPPI has clocked appreciable sales turnover of Rs 52 crore despite the lockdown and testing times in the month of April as compared to Rs 42 crore achieved in March 2020. As the product basket of PMBJP consists of all the essential medicines enlisted in the NLEM other than lab regents and stents, BPPI has adequate stock of the medicines which are currently under demand viz. Face mask, hydroxychloroquine, paracetamol and azithromycin, the press release added.

BPPI has sold about 6 lacs facemasks, 50 lacs tablets of hydroxychloroquine in the month of March and April. Further, orders for 60 lacs hydroxychloroquine tablets has also been placed. Envisioning current market demand, BPPI has also placed purchase orders for procurement of these medicines so as to have enough stock for the next six months.

Following the lockdown measures in place, over 6,300 PMBJKs are functioning across the nation, covering 726 districts of the country. Supporting the governments initiative of practising social distancing, pharmacists at the PMBJK, now popularly known as “Swasth Ke Sipahi” are undertaking the delivery of medicines to patients and elderly people at their doorstep.